Early Phase Administration of Hematopoietic Stem Cell Transplantation to Prevent Early Relapse for Infants with Acute Lymphoblastic Leukemia and MLL Gene Rearrangement; a Report From the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) Trial MLL03
Katsuyoshi Koh(Saitama Children's Medical Center), Eiichi Ishii(Japan Medical Association), Daisuke Tomizawa(National Center For Child Health and Development), Takako Miyamura(The University of Osaka), Koji Kato, Yoshihiro Takahashi, Masahito Tsurusawa(Aichi Medical University), Masahiro Hirayama(Mie University), Tomohiko Taki(Kyorin University), Tomoyuki Watanabe(Aichi Gakuin University), Akiko Saito(Nagoya University Hospital), Takashi Sato(Kitasato University), Shuki Mizutani, Kanji Sugita(University of Yamanashi), Yutaka Saikawa(Kanazawa Medical University), Atsushi Ogawa(Niigata Cancer Center Hospital), Takeyuki Sato(Chiba University), Keizo Horibe(National Hospital Organization)
Cited by 2
Related Papers
Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration
|Journal of Clinical Oncology|2015|1k
NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity
|Nature Genetics|2016|473
Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse
|Blood|2011|402
Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia
|Journal of Clinical Oncology|2015|383